Hunt Globally: Deep Research AI Agents for Drug Asset Scouting in Investing, Business Development, and Search & Evaluation.

Bio-pharmaceutical innovation has shifted, with most new drug assets originating outside the U.S. and disclosed through non-English channels. This creates multi-billion-dollar risks for investors and development teams who struggle to find "under-the-radar" assets using current Deep Research AI agents. This paper proposes a benchmarking methodology and a tuned, tree-based self-learning Bioptic Agent to achieve complete, non-hallucinated scouting across heterogeneous, multilingual sources. The Bioptic Agent significantly outperforms other models in F1 score.